David Lieberman

Jan 6, 2025 | thelancet.com | Uri Ladabaum |Jason A. Dominitz |David Lieberman |Robert Schoen

FREE with registration!Log in or register to access the full article. References1. Chung, DC ∙ Gray, 2nd, DM ∙ Singh, H ∙ et al. A cell-free DNA blood-based test for colorectal cancer screeningN Engl J Med. 2024; 390:973-9832. Morgan, E ∙ Arnold, M ∙ Gini, A ∙ et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCANGut. 2023; 72:338-3443. Lin, JS ∙ Perdue, LA ∙ Henrikson, NB ∙ et al.

Oct 8, 2024 | giejournal.org | David Lieberman |M. Brian Fennerty

Richard E. Sampliner was born in Cleveland, Ohio in 1941 as the second son of a suburban general practitioner. He graduated valedictorian from University High School and matriculated to Yale University, where he majored in American Studies and graduated Magna Cum Laude in 1963. He attended Case Western Reserve University School of Medicine where he met his future wife, Linda.

May 3, 2024 | therighting.com | Howard Polskin |David Lieberman |Amy Reiter |Michael Lovito

Righting Originals represent articles and opinion pieces commissioned by the editors of TheRighting that reflect the mainstream and/or liberal perspective on Right-wing media.

Apr 1, 2024 | jamanetwork.com | Erica K. Barnell |David Lieberman |Elizabeth M. Wurtzler |Julie La Rocca

Multitarget Stool RNA Testing—Reply Multitarget Stool RNA Test for Colorectal Cancer Screening Erica K. Barnell, MD, PhD; Elizabeth M. Wurtzler, PhD; Julie La Rocca, MS; Thomas Fitzgerald, MS; Jessica Petrone, MD; Yansheng Hao, MD, PhD; Yiming Kang, PhD; Faith L. Holmes, MD; David A. Lieberman, MD Multitarget Stool RNA Testing Multitarget Stool RNA Testing Thomas F. Imperiale, MD; Philip Lavin, PhD; David F.

Mar 20, 2023 | oncologytube.com | David Lieberman

Dr. David Lieberman discusses the Geneoscopy: Efficacy of Non-Invasive Colorectal Cancer Screening Test Evaluated in the CRC-PREVENT Phase 3 Trial 1 day 1 Views Category: Description: Geneoscopy: Evaluating the Efficacy of a Non-Invasive Colorectal Cancer Screening Test: Findings from the CRC-PREVENT Phase 3 Trial Dr. David LiebermanBy David Lieberman, MDThe idea was to evaluate the efficacy of this Geneoscopy test to screen individuals age 45 and older for colorectal cancer.